1. ATIM-04. PHASE I IMMUNOVIROTHERAPY TRIAL OF IL-12 EXPRESSING HSV-1 (M032) IN PET DOGS WITH SPONTANEOUS HIGH GRADE GLIOMAS: A PRELIMINARY REPORT. (11th November 2019) Authors: Renee Chambers, M; Crossman, David; Foote, Jeremy; Koehler, Jey; Markert, James; Platt, Simon; Mitchell Self, D; Shores, Andy; Waters, Alicia; Yanke, Amy; Yancey Gillespie, G Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Author Correction: Identification of donor microbe species that colonize and persist long term in the recipient after fecal transplant for recurrent Clostridium difficile. (December 2017) Authors: Kumar, Ranjit; Yi, Nengjun; Zhi, Degui; Eipers, Peter; Goldsmith, Kelly; Dixon, Paula; Crossman, David; Crowley, Michael; Lefkowitz, Elliot; Rodriguez, J.; Morrow, Casey Journal: Npj biofilms and microbiomes Issue: Volume 3(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile. Issue 1 (December 2016) Authors: Kumar, Ranjit; Maynard, Craig; Eipers, Peter; Goldsmith, Kelly; Ptacek, Travis; Grubbs, J.; Dixon, Paula; Howard, Donna; Crossman, David; Crowley, Michael; Benjamin, William; Lefkowitz, Elliot; Weaver, Casey; Rodriguez, J.; Morrow, Casey Journal: BMC microbiology Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dietary Docosahexaenoic Acid Reduces Oscillatory Wall Shear Stress, Atherosclerosis, and Hypertension, Most Likely Mediated via an IL‐1–Mediated Mechanism. Issue 13 (3rd July 2018) Authors: Alfaidi, Mabruka A.; Chamberlain, Janet; Rothman, Alexander; Crossman, David; Villa‐Uriol, Maria‐Cruz; Hadoke, Patrick; Wu, Junxi; Schenkel, Torsten; Evans, Paul C.; Francis, Sheila E. Journal: Journal of the American Heart Association Issue: Volume 7:Issue 13(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer. (2nd November 2021) Authors: Arend, Rebecca C.; Scalise, Carly B.; Dholakia, Jhalak; Kamal, Maahum Z.; Thigpen, Haley B.; Crossman, David; Huh, Warner K.; Leath, Charles A. Journal: Cancer medicine Issue: Volume 10:Number 22(2021) Page Start: 8238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IMMU-09. HUMAN MICROBIOTA INFLUENCE THE EFFICACY OF IMMUNOTHERAPY IN A MOUSE MODEL OF GLIOBLASTOMA. (12th November 2021) Authors: Dees, Kory; Koo, Hyunmin; Humphreys, James; Hakim, Joseph; Crossman, David; Crowley, Michael; Nabors, L Burt; Benveniste, Etty; Morrow, Casey; McFarland, Braden Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial. Issue 10216 (21st December 2019) Authors: Mullen, Michael; Jin, Xu Yu; Child, Anne; Stuart, A Graham; Dodd, Matthew; Aragon-Martin, José Antonio; Gaze, David; Kiotsekoglou, Anatoli; Yuan, Li; Hu, Jiangting; Foley, Claire; Van Dyck, Laura; Knight, Rosemary; Clayton, Tim; Swan, Lorna; Thomson, John D R; Erdem, Guliz; Crossman, David; Flath... Journal: Lancet Issue: Volume 394:Issue 10216(2019) Page Start: 2263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial. Issue 10216 (21st December 2019) Authors: Mullen, Michael; Jin, Xu Yu; Child, Anne; Stuart, A Graham; Dodd, Matthew; Aragon-Martin, José Antonio; Gaze, David; Kiotsekoglou, Anatoli; Yuan, Li; Hu, Jiangting; Foley, Claire; Van Dyck, Laura; Knight, Rosemary; Clayton, Tim; Swan, Lorna; Thomson, John D R; Erdem, Guliz; Crossman, David; Flath... Journal: Lancet Issue: Volume 394:Issue 10216(2019) Page Start: 2263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. New developments in percutaneous coronary intervention. Issue 7407 (17th July 2003) Authors: Gunn, Julian; Crossman, David; Grech, Ever D; Cumberland, David Journal: BMJ Issue: Volume 327:Issue 7407(2003) Page Start: 150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P0046ZHX2 DOWNREGULATION DUE INSERTIONS AND DELETIONS IN THE HAS2-ZHX2 INTERGENIC REGION PREDISPOSE TO PODOCYTE DISEASE RELAPSE. (6th June 2020) Authors: Del Nogal Avila, Maria; Das, Ranjan; Kharlyngdoh, Joubert; Molina Jijon, Eduardo; Donoro Blazquez, Hector; Gambut, Stephanie; Crowley, Michael; Crossman, David; Gbadagesin, Rasheed A; Nagel, Stefan; Avila Casado, Carmen; Clement, Lionel; Mace, Camille; Chugh, Sumant S Journal: Nephrology dialysis transplantation Issue: Volume 35(2020)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗